Puritan wins new Australian patents for flocked swabs

November 2013
Medical Device Daily;11/20/2013, Vol. 17 Issue 225, p5
The article reports that Puritan Medical Products, a manufacturer of specimen collection devices has been awarded two new Australian patents for its high performance flocked swabs, the HydraFlock swab and PurFlock Ultra swab.


Related Articles

  • Liquid based microbiology. Schmidt, Amanda // MLO: Medical Laboratory Observer;Aug2017, Vol. 49 Issue 8, p50 

    The article discusses the transition of laboratories to liquid-based microbiology (LBM) collection and transport systems for their surveillance programs.

  • Riding the waves of lab automation. Larkin Nolen, John David // MLO: Medical Laboratory Observer;Aug2017, Vol. 49 Issue 8, p38 

    The article discusses the automation of the clinical laboratory. Topics covered include the changes in the practice of laboratory medicine, the process by which automation became an indispensable part of the clinical lab and the areas of the lab that the economic and labor climates for...

  • Bacterial carbohydrate-degrading capacity in foal faeces: changes from birth to pre-weaning and the impact of maternal supplementation with fermented feed products. Faubladier, Céline; Julliand, Véronique; Danel, Justine; Philippeau, Christelle // British Journal of Nutrition;Sep2013, Vol. 110 Issue 6, p1040 

    The present study aimed at (1) describing age-related changes in faecal bacterial functional groups involved in carbohydrate degradation and in their activities in foals (n 10) from birth (day (d) 0) to 6 months (d180) and (2) investigating the effect of maternal supplementation (five mares per...

  • Barriers and Facilitators to Colorectal Cancer Screening Within a Hispanic Population. Byrd, Theresa L.; Calderón-Mora, Jessica; Salaiz, Rebekah; Shokar, Navkiran K. // Hispanic Health Care International;Mar2019, Vol. 17 Issue 1, p23 

    Introduction:: Colorectal cancer (CRC) is the third leading cancer cause of death among US Hispanics. CRC screening among the Hispanic population is lower compared with non-Hispanic Whites. Method:: The purpose of this qualitative, exploratory study was to better understand the barriers and...

  • Enzo Biochem, NEI jointly file U.S. patent application.  // Medical Device Daily;5/8/2013, Vol. 17 Issue 89, p3 

    The article reports that Enzo Biochem and the U.S. National Institutes of Health's (NIH) National Eye Institute (NEI) have jointly filed a patent application for a product platform directed to immune modulation for autoimmune disease management at the U.S. Patent and Trademark Office in April 2013.

  • Europe `sliding back' in technology.  // Nature;3/14/1996, Vol. 380 Issue 6570, p94 

    Informs that a 1996 European Commission annual survey of industry, entitled `Panorama of Industry,' warned that the European Union's (EU) declining share of patents could threaten its commercial competitiveness in some fields; The deterioration of the EU's already weak position in the...

  • THE RESPONSIBILITY OF THE RULEMAKER: COMPARATIVE APPROACHES TO PATENT ADMINISTRATION REFORM. Thomas, John R. // Berkeley Technology Law Journal;Spring2002, Vol. 17 Issue 2, p727 

    Compares approaches to patent administration reform. Importance of patent quality; Responsibilities of patent administrators; Proposals for patent administration reform.

  • Valuation of Patent Licenses. Hagelin, Ted // Texas Intellectual Property Law Journal;Spring2004, Vol. 12 Issue 3, p423 

    Focuses on the valuation of patent licenses in the U.S. Value of patent license to the industry standard method; Popularity of the 25 Percent Rule as a license valuation method; Calculation of the value of the patent license.

  • Beware of the troll. Macdonald, Morag // Lawyer;9/26/2005, Vol. 19 Issue 37, p26 

    Explains why Europe needs to be prepared with patent troll, a phenomenon in which a company licenses out the patents and enforces them against those who refuse to take a license. Prevalence of the phenomenon in the United States; Reasons why Europe is less attractive to the business model of...

  • The Case for Global Patent Protection. Ganorkar, Chaaya; Korth, Christopher // Pharmaceutical Executive;May2000, Vol. 20 Issue 5, p76 

    Addresses the concerns of pharmaceutical companies on patent infringement. Organizations that have reasons for having stronger global patent laws; Discussion on the status of patent systems around the world; Strategy for developing a standardized global patent system with stringent operating...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics